1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 04 JANUARY 2016

CNS Drug News 04 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Compliance Will Be Key In Future CNS Medication
Industry Trend Analysis - LID Success Will Allow Adamas To Grow
Industry Brief - Intec Receives IRB Approval To Initiate AP-COLD Phase III PD Trial
Industry Brief - ADS-5102 Phase III EASE LID Trial Meets Primary Endpoint
Industry Brief - Enrolment Begins In ND0612H Phase II Trial In Advanced PD
Industry Trend Analysis - Laquinimod Viability In Doubt
Industry Brief - GeNeuro Initiates GNbAC1 Phase IIb Trial In RRMS
Industry Trend Analysis - Fast Track Designation Supporting Mid-term Operations
Industry Brief - Aquinnah Secures USD5mn Investment From Takeda To Advance ALS Therapies
Industry Brief - Radicut Approved In South Korea For ALS
Industry Brief - Sanbio/Sunovion Begin Regenerative Therapy Phase IIb Trial For Chronic Stroke
Industry Brief - ICT Begins Enrolment For ITI-007 Phase III Trials In Bipolar Depression
Industry Brief - Pristiq Phase III Paediatric MDD Study Misses Primary Endpoint
Industry Brief - EMA Accepts Fanaptum MAA For Schizophrenia In Adults
Industry Brief - Egalet Submits Arymo NDA In US
Industry Brief - Antares Gains FDA Sumatriptan Approval
Industry Brief - FDA Approves Merck's Bridion For Reversal Of NMB
Industry Brief - Hikma Gains FDA Neostigmine Approval
Industry Brief - CHMP Accepts AcelRx' ARX-04 MAA For Centralised Review
Industry Brief - Depomed Acquires Certain Rights To Cebranopadol From Grunenthal
Industry Brief - First Patient Enrolled In Phase III Efficacy Trial Of CAM2038
Industry Brief - Neurelis Receives FDA ODD For NRL-1 In Acute Repetitive Seizures
Industry Brief - FDA Accepts Zogenix' IND For ZX003 Phase III Trial In Dravet Syndrome
Industry Brief - Interim Results From Alexza AZ-002 Phase IIa Study In ARS
Industry Trend Analysis - ULS Indication Will Not Revitalise Xeomin
Industry Brief - Ionis Earns Milestone In Neurology Collaboration With Biogen
Industry Brief - Cantabio/Gardedam Complete Merger

Table Of Contents

CNS Drug News 04 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Traumatic Brain Injury in 21 Major Markets Traumatic brain injury (TBI) or acquired brain injury is a non-specific term describing ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.